California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on April 27, 2026

Apr. 27, 2026

Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease

Indeterminate GlobeNewswire

Apr. 27, 2026

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Apr. 27, 2026

Asgard Therapeutics announces oral presentation at ASGCT 2026, showcasing advanced preclinical data on AT-108 – its first-in-class, off-the-shelf, gene-based cancer immunotherapy

Indeterminate GlobeNewswire

Apr. 27, 2026

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Cellectis présente sa plateforme d’édition épigénétique pour éteindre des gènes sans modifier l’ADN, lors du congrès annuel de l’ASGCT

Indeterminate GlobeNewswire

Apr. 27, 2026

Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Beta Bionics to Present at the Bank of America Securities Health Care Conference

Indeterminate GlobeNewswire

Apr. 27, 2026

Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering

Indeterminate GlobeNewswire

Apr. 27, 2026

InspireMD to Announce First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Apr. 27, 2026

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions

Indeterminate GlobeNewswire

Apr. 27, 2026

The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California

Indeterminate GlobeNewswire

Apr. 27, 2026

Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

TOMI Environmental Positioned for Accelerated Growth as Robotaxi Market Rapidly Expands

Indeterminate GlobeNewswire

Apr. 27, 2026

Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production

Indeterminate GlobeNewswire